p21Waf1/Cip1 plays a critical role in modulating senescence through changes of DNA methylation

Journal of Cellular Biochemistry
Quan Hui ZhengTanjun Tong

Abstract

It has been reported that genomic DNA methylation decreases gradually during cell culture and an organism's aging. However, less is known about the methylation changes of age-related specific genes in aging. p21(Waf1/Cip1) and p16(INK4a) are cyclin-dependent kinase (Cdk) inhibitors that are critical for the replicative senescence of normal cells. In this study, we show that p21(Waf1/Cip1) and p16(INK4a) have different methylation patterns during the aging process of normal human 2BS and WI-38 fibroblasts. p21(Waf1/Cip1) promoter is gradually methylated up into middle-aged fibroblasts but not with senescent fibroblasts, whereas p16(INK4a) is always unmethylated in the aging process. Correspondently, the protein levels of DNA methyltransferase 1 (DNMT1) and DNMT3a increase from young to middle-aged fibroblasts but decrease in the senescent fibroblasts, while DNMT3b decreases stably from young to senescent fibroblasts. p21(Waf1/Cip1) promoter methylation directly represses its expression and blocks the radiation-induced DNA damage-signaling pathway by p53 in middle-aged fibroblasts. More importantly, demethylation by 5-aza-CdR or DNMT1 RNA interference (RNAi) resulted in an increased p21(Waf1/Cip1) level and premature senescence o...Continue Reading

References

Jan 1, 1987·Experimental Cell Research·D S FairweatherG P Margison
Nov 1, 1989·Journal of Gerontology·L L Mays-Hoopes
Jun 3, 1983·Science·V L Wilson, P A Jones
Jul 24, 1982·Nucleic Acids Research·R J Shmookler Reis, S Goldstein
Sep 26, 1995·Proceedings of the National Academy of Sciences of the United States of America·G P DimriO Pereira-Smith
May 15, 1995·Genes & Development·C J Sherr, J M Roberts
Dec 16, 1993·Nature·Y XiongD Beach
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·J P IssaS B Baylin
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·D A AlcortaJ C Barrett
Jul 1, 1999·Genes & Development·C J Sherr, J M Roberts
Dec 10, 1999·Critical Reviews in Oncology/hematology·J P Issa
Feb 29, 2000·The Journal of Biological Chemistry·S MilutinovicM Szyf
Sep 27, 2000·Human Molecular Genetics·T H Bestor
Dec 2, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·N SitteK J Davies
Mar 10, 2001·Experimental Cell Research·J W Rocco, D Sidransky
Mar 22, 2001·The Journal of Biological Chemistry·J I Young, J R Smith
Oct 19, 2001·The Journal of Biological Chemistry·J DuanT Tong
Aug 30, 2002·The International Journal of Biochemistry & Cell Biology·Peter NeumeisterRichard G Pestell
Oct 18, 2002·European Journal of Biochemistry·Mehrnaz FatemiAlbert Jeltsch
Dec 24, 2002·Nature Genetics·Marie-France RobertA Robert MacLeod
May 3, 2003·Ageing Research Reviews·Bruce Richardson
May 30, 2003·Molecular and Cellular Biology·Wei-Guo ZhuGregory A Otterson
Dec 9, 2003·Mechanisms of Ageing and Development·Liang LiuTrygve O Tollefsbol
Jan 15, 2004·The Journal of Biological Chemistry·Wei-Guo ZhuGregory A Otterson
May 13, 2004·The Journal of Biological Chemistry·Wenjie ZhengTanjun Tong
Sep 21, 2004·The Journal of Biological Chemistry·Jian-Hua ChenC Nicholas Hales
Dec 8, 2004·Human Mutation·Y L JiangE Viegas-Péquignot

❮ Previous
Next ❯

Citations

Oct 21, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Qanhui ZhengYong Zhao
Nov 11, 2010·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Kun LiuZhaohui Wang
May 3, 2013·In Vitro Cellular & Developmental Biology. Animal·Guo ShaoShi-Wen Jiang
Aug 12, 2009·Cell Research·Francesco P FiorentinoAntonio Giordano
Dec 24, 2011·Assay and Drug Development Technologies·Timo WeilandSascha Venturelli
Jul 10, 2009·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Nashi WidodoRenu Wadhwa
Mar 13, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Kathleen M GilbertSarah J Blossom
Aug 6, 2008·Molecular and Cellular Biology·Liwei MaTanjun Tong
Jun 4, 2010·American Journal of Physiology. Cell Physiology·Tomer AvrahamBabak J Mehrara
Mar 21, 2013·BMC Cell Biology·Jun-Qi GuoJian-Ming Tan
Aug 25, 2010·Cellular and Molecular Life Sciences : CMLS·Yu HuangTanjun Tong
Feb 9, 2016·Cell Reports·Roméo Sébastien BlancStéphane Richard
Apr 2, 2011·Mechanisms of Ageing and Development·Jing NiuTanjun Tong
Oct 23, 2010·Pharmacology & Therapeutics·Antonio Paolo BeltramiCarlo Alberto Beltrami
Apr 1, 2011·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Wen-Chung TsaiJong-Hwei S Pang
Nov 6, 2012·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Jun DangQin-Tao Wang
Jul 12, 2016·Rejuvenation Research·Léa MoulinRomain Debret
Dec 12, 2018·Journal of Clinical Pharmacology·Wangda ZhouCarlos Appiani
Oct 16, 2019·Oxidative Medicine and Cellular Longevity·Gen-Xiang MaoJing Yan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.